POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 74 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,648,000 | -53.9% | 750,000 | -4.8% | 0.08% | -7.2% |
Q3 2021 | $5,743,000 | -63.6% | 787,745 | -50.0% | 0.08% | -19.4% |
Q2 2021 | $15,786,000 | +109.8% | 1,575,490 | +100.0% | 0.10% | +8.4% |
Q1 2021 | $7,523,000 | -12.9% | 787,745 | 0.0% | 0.10% | +2.2% |
Q4 2020 | $8,642,000 | +23.7% | 787,745 | 0.0% | 0.09% | -8.8% |
Q3 2020 | $6,987,000 | – | 787,745 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,043,267 | $10,454,000 | 1.67% |
Boxer Capital, LLC | 1,251,055 | $12,536,000 | 0.44% |
Pentwater Capital Management LP | 4,967,227 | $49,772,000 | 0.41% |
KNOTT DAVID M | 29,566 | $296,000 | 0.10% |
Perceptive Advisors | 1,575,490 | $15,786,000 | 0.10% |
Virtus ETF Advisers LLC | 24,287 | $243,000 | 0.10% |
Advisory Services Network, LLC | 256,772 | $2,573,000 | 0.08% |
J. Goldman & Co LP | 202,501 | $2,029,000 | 0.08% |
Ikarian Capital, LLC | 85,837 | $861,000 | 0.07% |
Regent Investment Management LLC | 25,000 | $251,000 | 0.06% |